|
US7628980B2
(en)
|
2000-11-23 |
2009-12-08 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
US7097842B2
(en)
|
2000-11-23 |
2006-08-29 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
US7445924B2
(en)
*
|
2000-11-23 |
2008-11-04 |
Bavarian Nordic A/S |
Modified Vaccinia Ankara virus variant and cultivation method
|
|
HU230198B1
(hu)
*
|
2000-11-23 |
2015-10-28 |
Bavarian Nordic A/S |
Módosított Vacciniavírus Ankara-variáns
|
|
EP1357127A1
(de)
*
|
2002-04-10 |
2003-10-29 |
Immusystems GmbH |
CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
|
|
EP1420822B2
(en)
*
|
2002-04-19 |
2017-07-05 |
Bavarian Nordic A/S |
Modified vaccinia virus ankara for the vaccination of neonates
|
|
UA82479C2
(uk)
*
|
2002-05-16 |
2008-04-25 |
Бавариан Нордика А/С |
Міжгенні регіони як сайти вставки в геном модифікованого вірусу коров'ячої віспи ankara (mva)
|
|
US7501127B2
(en)
|
2002-05-16 |
2009-03-10 |
Bavarian Nordic A/S |
Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara
|
|
AU2003264144C1
(en)
*
|
2002-09-05 |
2009-12-17 |
Bavarian Nordic A/S |
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
|
|
JP5052893B2
(ja)
|
2003-02-20 |
2012-10-17 |
アメリカ合衆国 |
ポックスベクターにおける新規の挿入部位
|
|
EP1518932A1
(en)
*
|
2003-09-29 |
2005-03-30 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Modified vaccinia virus Ankara (MVA) mutant and use thereof
|
|
US7423155B2
(en)
|
2003-11-14 |
2008-09-09 |
3M Innovative Properties Company |
N-sulfonyldicarboximide containing tethering compounds
|
|
DE602004009743T2
(de)
|
2003-11-24 |
2008-08-28 |
Bavarian Nordic A/S |
Promotoren zur Expression in modifiziertem Vaccinia Virus Ankara
|
|
DE102004003572A1
(de)
*
|
2004-01-23 |
2005-08-18 |
Bavarian Nordic A/S |
Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens
|
|
US20090269365A1
(en)
*
|
2005-04-20 |
2009-10-29 |
University Of Washington |
Immunogenic vaccinia peptides and methods of using same
|
|
EP1835031A1
(en)
|
2006-03-14 |
2007-09-19 |
Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe |
Use of a recombinant modified vaccinia virus Ankara (MVA) for the treatment of type I hypersensitivity in a living animal including humans
|
|
US7607323B1
(en)
|
2007-10-16 |
2009-10-27 |
Hall Charles F |
Curl resistant shirt collar and method of fabricating same
|
|
US8691502B2
(en)
|
2008-10-31 |
2014-04-08 |
Tremrx, Inc. |
T-cell vaccination with viral vectors via mechanical epidermal disruption
|
|
US9005632B2
(en)
|
2009-11-20 |
2015-04-14 |
Takeda Vaccines, Inc. |
Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains
|
|
US9011874B2
(en)
|
2009-11-20 |
2015-04-21 |
Takeda Vaccines, Inc. |
Compositions, methods and uses for poxvirus elements in vaccine constructs
|
|
WO2011087839A1
(en)
|
2009-12-22 |
2011-07-21 |
Baxter International Inc. |
Vaccine to influenza a virus
|
|
WO2012151272A2
(en)
|
2011-05-02 |
2012-11-08 |
Tremrx, Inc. |
T-cell vaccination with viral vectors via mechanical epidermal disruption
|
|
DE102013004595A1
(de)
|
2013-03-15 |
2014-09-18 |
Emergent Product Development Germany Gmbh |
RSV-Impfstoffe
|
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
JP7060324B2
(ja)
|
2013-12-20 |
2022-04-26 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
ネオ抗原ワクチンによる併用療法
|
|
US20170021009A1
(en)
*
|
2014-03-10 |
2017-01-26 |
Arizona Board Of Regents On Behalf Of Arizona State |
Heat Inactivated Poxvirus Improves Vaccination Results
|
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
EP3234130B1
(en)
|
2014-12-19 |
2020-11-25 |
The Broad Institute, Inc. |
Methods for profiling the t-cell- receptor repertoire
|
|
NL2014148B1
(en)
|
2015-01-16 |
2017-01-05 |
Univ Erasmus Med Ct Rotterdam |
Combination vaccine for camelids.
|
|
EP4122492A1
(en)
*
|
2015-02-25 |
2023-01-25 |
Memorial Sloan Kettering Cancer Center |
Use of inactivated nonreplicating modified vaccinia virus ankara (mva)as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
|
|
JP6913032B2
(ja)
|
2015-05-20 |
2021-08-04 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
共通ネオ抗原
|
|
TW202241500A
(zh)
|
2015-06-09 |
2022-11-01 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
|
FR3042121A1
(fr)
|
2015-10-08 |
2017-04-14 |
Jean-Marc Limacher |
Composition anti-tumorale
|
|
AU2017254477A1
(en)
|
2016-04-18 |
2018-11-01 |
Jennifer G. ABELIN |
Improved HLA epitope prediction
|
|
EP3574116A1
(en)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
CA3062549A1
(en)
|
2017-05-15 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Stable virus-containing composition
|
|
EP3624851A1
(en)
|
2017-05-15 |
2020-03-25 |
Janssen Vaccines & Prevention B.V. |
Stable virus-containing composition
|
|
WO2019089755A1
(en)
|
2017-10-31 |
2019-05-09 |
Western Oncolytics Ltd. |
Platform oncolytic vector for systemic delivery
|
|
US12239699B2
(en)
|
2018-09-11 |
2025-03-04 |
Shanghai Public Health Clinical Center |
Immunogen for broad-spectrum influenza vaccine and application thereof
|
|
US20210382068A1
(en)
|
2018-10-02 |
2021-12-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|
|
EP4329786A4
(en)
|
2021-04-30 |
2024-12-11 |
KaliVir Immunotherapeutics, Inc. |
Oncolytic viruses for modified mhc expression
|
|
WO2023077147A2
(en)
|
2021-11-01 |
2023-05-04 |
Pellis Therapeutics, Inc. |
T-cell vaccines for patients with reduced humoral immunity
|
|
EP4519445A4
(en)
*
|
2022-05-04 |
2026-06-24 |
Univ Maryland |
RNA VECTORS WITH HAIRPIN INSERTS
|
|
US20230364227A1
(en)
|
2022-05-12 |
2023-11-16 |
Pellis Therapeutics, Inc. |
Poxvirus adjuvant for t-cell vaccination
|
|
WO2024015892A1
(en)
|
2022-07-13 |
2024-01-18 |
The Broad Institute, Inc. |
Hla-ii immunopeptidome methods and systems for antigen discovery
|
|
US12531162B1
(en)
*
|
2023-05-31 |
2026-01-20 |
Northeastern University |
Multi-dimensional phenotypic space for genotype to phenotype mapping and intelligent design of cancer drug therapies using a deep learning net
|
|
US12562256B2
(en)
*
|
2023-11-07 |
2026-02-24 |
New York University |
Systems, methods and computer-accessible medium for identifying target pairs for CAR-T therapy
|
|
FR3160186A1
(fr)
|
2024-03-13 |
2025-09-19 |
Odimma Therapeutics |
Vecteur non-viral pour transcription augmentee
|
|
FR3171450A1
(fr)
|
2025-01-17 |
2026-07-24 |
Odimma Therapeutics |
Virus enveloppé pour la transfection d’acides nucléiques exogènes.
|